With respect to AD, the assessment of occurrence of HP‐tau seen in pre‐tangles, tangles, neurites and NP and the assessment of the occurrence of Aβ in the parenchyma as variform plaques or as CAA is the diagnostic mode of choice. The gene discussed is MAPT; the disease is Alzheimer disease.